March 19, 2026
A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone marrow—may help explain why people with IBD have a higher risk of colorectal cancer, according to a preclinical study led by senior author Dr. Randy Longman.